It is a health-transforming outcome by any non-comparative standard
I combine GLP-1 therapy with nutrition coaching, movement strategies, and regular check-ins
The reductions in lean mass do not necessarily indicate pathological muscle loss, as improvements in body composition, physical function, and quality of life have been reported with semaglutide and tirzepatide in subanalyses of the STEP-1 and SURMOUNT-1 programs [7,8]
We proposed to use two risk indicators, Hierarchical Condition Category (HCC) risk scores and the proportion of patients with dual eligible status, dual eligible proportion, to calculate the complex patient scoring adjustment to ASM participants' final ( scores
Common side effects include nausea and gastrointestinal discomfort, which are often dose-dependent